Investigating non-inferiority or equivalence in time-to-event data under non-proportional hazards

被引:2
作者
Moellenhoff, Kathrin [1 ]
Tresch, Achim [2 ,3 ,4 ]
机构
[1] Heinrich Heine Univ, Math Inst, D-40225 Dusseldorf, Germany
[2] Univ Cologne, Inst Med Stat & Computat Biol, Fac Med, Cologne, Germany
[3] Univ Cologne, CEDAD, Cologne, Germany
[4] Univ Cologne, Ctr Data & Simulat Sci, Cologne, Germany
关键词
Equivalence; Non-inferiority; Non-proportional hazards; Survival analysis; Time-to-event data; REGRESSION-MODELS; CLINICAL-TRIALS; SURVIVAL; TESTS; NONINFERIORITY; DIFFERENCE;
D O I
10.1007/s10985-023-09589-5
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
The classical approach to analyze time-to-event data, e.g. in clinical trials, is to fit Kaplan-Meier curves yielding the treatment effect as the hazard ratio between treatment groups. Afterwards, a log-rank test is commonly performed to investigate whether there is a difference in survival or, depending on additional covariates, a Cox proportional hazard model is used. However, in numerous trials these approaches fail due to the presence of non-proportional hazards, resulting in difficulties of interpreting the hazard ratio and a loss of power. When considering equivalence or non-inferiority trials, the commonly performed log-rank based tests are similarly affected by a violation of this assumption. Here we propose a parametric framework to assess equivalence or non-inferiority for survival data. We derive pointwise confidence bands for both, the hazard ratio and the difference of the survival curves. Further we propose a test procedure addressing non-inferiority and equivalence by directly comparing the survival functions at certain time points or over an entire range of time. Once the model's suitability is proven the method provides a noticeable power benefit, irrespectively of the shape of the hazard ratio. On the other hand, model selection should be carried out carefully as misspecification may cause type I error inflation in some situations. We investigate the robustness and demonstrate the advantages and disadvantages of the proposed methods by means of a simulation study. Finally, we demonstrate the validity of the methods by a clinical trial example.
引用
收藏
页码:483 / 507
页数:25
相关论文
共 38 条
[1]   BOOTSTRAPPING THE KAPLAN-MEIER ESTIMATOR [J].
AKRITAS, MG .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1986, 81 (396) :1032-1038
[2]   MULTI-PARAMETER HYPOTHESIS-TESTING AND ACCEPTANCE SAMPLING [J].
BERGER, RL .
TECHNOMETRICS, 1982, 24 (04) :295-300
[3]  
BRADLEY RA, 1962, BIOMETRIKA, V49, P205, DOI 10.1093/biomet/49.1-2.205
[4]   Assessing the similarity of dose response and target doses in two non-overlapping subgroups [J].
Bretz, Frank ;
Moellenhoff, Kathrin ;
Dette, Holger ;
Liu, Wei ;
Trampisch, Matthias .
STATISTICS IN MEDICINE, 2018, 37 (05) :722-738
[5]   HOW TO ESTABLISH EQUIVALENCE WHEN DATA ARE CENSORED - A RANDOMIZED TRIAL OF TREATMENTS FOR B-NON-HODGKIN LYMPHOMA [J].
COMNOUGUE, C ;
RODARY, C ;
PATTE, C .
STATISTICS IN MEDICINE, 1993, 12 (14) :1353-1364
[6]  
Cox DavidRoxbee., 1984, ANAL SURVIVAL DATA, DOI 10.1201/9781315137438/analysis-survival-data-cox-oakes
[7]  
COX DR, 1972, J R STAT SOC B, V34, P187
[8]   Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics [J].
D'Agostino, RB ;
Massaro, JM ;
Sullivan, LM .
STATISTICS IN MEDICINE, 2003, 22 (02) :169-186
[9]   Methods for Equivalence and Noninferiority Testing [J].
da Silva, Gisela Tunes ;
Logan, Brent R. ;
Klein, John P. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) :120-127
[10]   Bootstrap- and permutation-based inference for the Mann-Whitney effect for right-censored and tied data [J].
Dobler, Dennis ;
Pauly, Markus .
TEST, 2018, 27 (03) :639-658